ORGANOGENESIS HOLDINGS INC. Operating Income
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Operating Income of -$50.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. operating income (loss) for the quarter ending 2026-06-30 was -$50.99M.
- ORGANOGENESIS HOLDINGS INC. operating income (loss) for the quarter ending 2026-03-31 was -$68.89M.
- ORGANOGENESIS HOLDINGS INC. operating income (loss) for the quarter ending 2025-12-31 was $63.29M, a 519.33% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. operating income (loss) for the quarter ending 2025-09-30 was $20.73M, a 232.06% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. operating income (loss) for fiscal 2025 was $44.69M.
- ORGANOGENESIS HOLDINGS INC. operating income (loss) for fiscal 2024 was -$1.28M, a 110.24% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. operating income (loss) for fiscal 2023 was $12.53M, a 43.84% decline from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. operating income (loss) for fiscal 2022 was $22.30M, a 69.12% decline from fiscal 2021.
| Period end | Operating Income (Loss) 1 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$50.99M 10-Q · filed 2026-08-06 | -$119.88M 10-Q · filed 2026-08-06 | -$56.59M derived: sum of 3 quarters · filed 2026-08-06 | -$35.87M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | -$68.89M 10-Q · filed 2026-05-07 | -$5.60M derived: sum of 2 quarters · filed 2026-05-07 | $15.13M derived: sum of 3 quarters · filed 2026-05-07 | $2.55M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | $63.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $84.02M derived: sum of 2 quarters · filed 2026-02-26 | $71.44M derived: sum of 3 quarters · filed 2026-08-06 | $44.69M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $20.73M 10-Q · filed 2025-11-06 | $8.15M derived: sum of 2 quarters · filed 2026-08-06 | -$18.59M 10-Q · filed 2025-11-06 | -$8.38M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | -$12.58M 10-Q · filed 2026-08-06 | -$39.32M 10-Q · filed 2026-08-06 | -$29.10M derived: sum of 3 quarters · filed 2026-08-06 | -$22.86M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | -$26.75M 10-Q · filed 2026-05-07 | -$16.53M derived: sum of 2 quarters · filed 2026-05-07 | -$10.29M derived: sum of 3 quarters · filed 2026-05-07 | -$24.18M derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | $10.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $16.46M derived: sum of 2 quarters · filed 2026-02-26 | $2.57M derived: sum of 3 quarters · filed 2026-02-26 | -$1.28M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $6.24M 10-Q · filed 2025-11-06 | -$7.65M derived: sum of 2 quarters · filed 2025-11-06 | -$11.50M 10-Q · filed 2025-11-06 | -$12.77M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-06-30 | -$13.89M 10-Q · filed 2025-08-07 | -$17.74M 10-Q · filed 2025-08-07 | -$19.01M derived: sum of 3 quarters · filed 2026-02-26 | -$10.96M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-03-31 | -$3.85M 10-Q · filed 2025-05-08 | -$5.12M derived: sum of 2 quarters · filed 2026-02-26 | $2.93M derived: sum of 3 quarters · filed 2026-02-26 | $12.67M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2023-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.78M derived: sum of 2 quarters · filed 2026-02-26 | $16.53M derived: sum of 3 quarters · filed 2026-02-26 | $12.53M 10-K · filed 2026-02-26 | |||||
| 2023-09-30 | $8.05M 10-Q · filed 2024-11-12 | $17.80M derived: sum of 2 quarters · filed 2024-11-12 | $13.79M 10-Q · filed 2024-11-12 | $22.51M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2023-06-30 | $9.74M 10-Q · filed 2024-08-08 | $5.74M 10-Q · filed 2024-08-08 | $14.46M derived: sum of 3 quarters · filed 2025-02-27 | $16.24M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2023-03-31 | -$4.00M 10-Q · filed 2024-05-09 | $4.72M derived: sum of 2 quarters · filed 2025-02-27 | $6.50M derived: sum of 3 quarters · filed 2025-02-27 | $18.43M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2022-12-31 | $8.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $10.50M derived: sum of 2 quarters · filed 2025-02-27 | $22.43M derived: sum of 3 quarters · filed 2025-02-27 | $22.30M 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | $1.78M 10-Q · filed 2023-11-09 | $13.71M derived: sum of 2 quarters · filed 2023-11-09 | $13.59M 10-Q · filed 2023-11-09 | $33.34M derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2022-06-30 | $11.94M 10-Q · filed 2023-08-09 | $11.81M 10-Q · filed 2023-08-09 | $31.56M derived: sum of 3 quarters · filed 2024-02-29 | $47.82M derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2022-03-31 | -$128.00K 10-Q · filed 2023-05-10 | $872.00K 10-Q · filed 2022-05-10 | $19.62M derived: sum of 2 quarters · filed 2024-02-29 | $35.89M derived: sum of 3 quarters · filed 2024-02-29 | $59.47M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $19.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $36.02M derived: sum of 2 quarters · filed 2024-02-29 | $59.60M derived: sum of 3 quarters · filed 2024-02-29 | $72.22M 10-K · filed 2024-02-29 | $72.92M 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | $16.26M 10-Q · filed 2022-11-09 | $39.85M derived: sum of 2 quarters · filed 2022-11-09 | $52.47M 10-Q · filed 2022-11-09 | $74.06M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2021-06-30 | $23.59M 10-Q · filed 2022-08-09 | $36.20M 10-Q · filed 2022-08-09 | $57.80M derived: sum of 3 quarters · filed 2023-03-01 | $80.60M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2021-03-31 | $12.62M 10-Q · filed 2022-05-10 | $34.21M derived: sum of 2 quarters · filed 2023-03-01 | $57.01M derived: sum of 3 quarters · filed 2023-03-01 | $54.76M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2020-12-31 | $21.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $44.39M derived: sum of 2 quarters · filed 2023-03-01 | $42.14M derived: sum of 3 quarters · filed 2023-03-01 | $26.70M 10-K · filed 2023-03-01 | $27.41M 10-K · filed 2021-03-16 | ||||
| 2020-09-30 | $22.80M 10-Q · filed 2021-11-09 | $22.98M 10-Q · filed 2020-11-09 | $20.55M derived: sum of 2 quarters · filed 2021-11-09 | $5.11M 10-Q · filed 2021-11-09 | $5.64M 10-Q · filed 2020-11-09 | $3.32M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | -$2.25M 10-Q · filed 2021-08-09 | -$17.34M 10-Q · filed 2021-08-09 | -$19.48M derived: sum of 3 quarters · filed 2022-03-01 | -$27.75M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-03-31 | -$15.08M 10-Q · filed 2021-05-11 | -$17.23M derived: sum of 2 quarters · filed 2022-03-01 | -$25.50M derived: sum of 3 quarters · filed 2022-03-01 | -$32.82M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$10.41M derived: sum of 2 quarters · filed 2022-03-01 | -$17.73M derived: sum of 3 quarters · filed 2022-03-01 | -$29.85M 10-K · filed 2022-03-01 | -$29.46M 10-K · filed 2020-03-09 | ||||
| 2019-09-30 | -$8.27M 10-Q · filed 2020-11-09 | -$15.58M derived: sum of 2 quarters · filed 2020-11-09 | -$27.70M 10-Q · filed 2020-11-09 | -$32.19M derived: sum of 4 quarters · filed 2020-11-09 | |||||
| 2019-06-30 | -$7.32M 10-Q · filed 2020-08-10 | -$19.44M 10-Q · filed 2020-08-10 | -$23.92M derived: sum of 3 quarters · filed 2020-08-10 | -$33.99M derived: sum of 4 quarters · filed 2020-08-10 | |||||
| 2019-03-31 | -$12.12M 10-Q · filed 2020-05-11 | -$16.60M derived: sum of 2 quarters · filed 2020-05-11 | -$26.67M derived: sum of 3 quarters · filed 2020-05-11 | -$43.70M derived: sum of 4 quarters · filed 2020-05-11 | |||||
| 2018-12-31 | -$4.48M 10-K · filed 2019-03-18 | -$14.55M derived: sum of 2 quarters · filed 2019-11-12 | -$31.57M derived: sum of 3 quarters · filed 2019-11-12 | -$51.56M 10-K · filed 2021-03-16 | |||||
| 2018-09-30 | -$10.07M 10-Q · filed 2019-11-12 | -$2.25M 10-Q · filed 2018-11-09 | -$27.09M derived: sum of 2 quarters · filed 2019-11-12 | -$47.08M 10-Q · filed 2019-11-12 | -$4.35M 10-Q · filed 2018-11-09 | -$49.48M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | -$17.02M 10-Q · filed 2019-08-09 | -$942.53K 10-Q · filed 2018-08-07 | -$37.01M 10-Q · filed 2019-08-09 | -$2.10M 10-Q · filed 2018-08-07 | -$39.41M derived: sum of 3 quarters · filed 2019-08-09 | -$42.02M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | -$19.98M 10-Q · filed 2019-05-10 | -$1.16M 10-Q · filed 2018-05-10 | -$22.38M derived: sum of 2 quarters · filed 2019-05-10 | -$25.00M derived: sum of 3 quarters · filed 2019-05-10 | -$22.50M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | -$2.40M 10-K · filed 2019-03-18 | -$5.02M derived: sum of 2 quarters · filed 2019-03-18 | -$2.52M derived: sum of 3 quarters · filed 2019-03-18 | -$5.49M 10-K · filed 2020-03-09 | -$4.59M 10-K · filed 2018-03-14 | ||||
| 2017-09-30 | -$2.62M 10-K · filed 2019-03-18 | -$2.85M 10-Q · filed 2017-11-14 | -$121.00K derived: sum of 2 quarters · filed 2019-03-18 | -$3.29M 10-Q · filed 2018-11-09 | -$4.39M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | $2.50M 10-K · filed 2019-03-18 | -$221.81K 10-Q · filed 2017-08-11 | -$440.46K 10-Q · filed 2018-08-07 | -$1.77M derived: sum of 3 quarters · filed 2019-03-18 | -$1.79M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | -$2.97M 10-K · filed 2019-03-18 | -$218.65K 10-Q · filed 2017-05-12 | -$4.27M derived: sum of 2 quarters · filed 2019-03-18 | -$4.28M derived: sum of 3 quarters · filed 2019-03-18 | -$4.28M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | -$1.30M 10-K · filed 2018-03-14 | -$1.31M derived: sum of 2 quarters · filed 2018-03-14 | -$1.31M derived: sum of 3 quarters · filed 2018-03-14 | -$8.78M 10-K · filed 2019-03-18 | -$208.70K 10-K · filed 2018-03-14 | ||||
| 2016-09-30 | -$14.49K 10-Q · filed 2017-11-14 | -$14.99K derived: sum of 2 quarters · filed 2017-11-14 | -$30.54K 10-Q · filed 2017-11-14 | ||||||
| 2016-06-30 | -$500.00 10-Q · filed 2017-08-11 | -$16.05K 10-Q · filed 2017-08-11 | |||||||
| 2016-03-31 | -$15.55K 10-Q · filed 2017-05-12 | ||||||||
| 2015-12-31 | -$25.16K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |